14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AJANTPHARM.NS
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

On Friday, Ajanta Pharma Limited stock price gained an impressive 6.71%
(Updated on May 03, 2024)

Buy or Hold candidate since Apr 29, 2024 Gain 7.74% PDF

The Ajanta Pharma Limited stock price gained 6.71% on the last trading day (Friday, 3rd May 2024), rising from ₹2,234.00 to ₹2,383.85. During the last trading day the stock fluctuated 7.62% from a day low at ₹2,360.05 to a day high of ₹2,540.00. The price has risen in 9 of the last 10 days and is up by 14.31% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 3 million more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately ₹6.60 billion.

The stock has broken the wide and horizontal trend up. Breaks like this are often followed by swift and strong movements, and any correction down to the breakline at approximately. ₹2,296.56 is considered to be a "second chance" to hit a potential runner. It is, however, important that volume does follow the price as false breaks may appear and it may move back into the horizontal trend. Based on the rectangle-formation theory the stock is predicted to reach ₹2,522.19 sometime during the next 3 months.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AJANTPHARM.NS Signals & Forecast

The Ajanta Pharma Limited stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at ₹2,227.83 and ₹2,162.95. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, April 16, 2024, and so far it has risen 15.44%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation A buy signal from a double bottom formation was found on Tuesday, April 16, 2024 with a target of ₹2,366.84. Despite whether the objective of the signal formation has been reached the stock may continue to perform well.

Support, Risk & Stop-loss for Ajanta Pharma Limited stock

On the downside, the stock finds support just below today's level from accumulated volume at ₹2,193.50 and ₹2,125.90. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Ajanta Pharma Limited finds support just below today's level at ₹2,193.50. If this is broken, then the next support from accumulated volume will be at ₹2,125.90 and ₹2,073.20.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved ₹179.95 (7.62%) between high and low. For the last week, the stock has had daily average volatility of 3.05%.

The Ajanta Pharma Limited stock is extremely overbought on RSI14 (86). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Our recommended stop-loss: ₹2,305.66 (-3.28%) (This stock has low daily movements and this gives low risk. The RSI14 is 86 and this increases the risk substantially. There is a buy signal from a pivot bottom found 12 days ago.)

Trading Expectations (AJANTPHARM.NS) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect Ajanta Pharma Limited to open at ₹2,427.97, and during the day (based on 14 day Average True Range), to move between ₹2,305.13 and ₹2,462.57, which gives a possible trading interval of +/-₹78.72 (+/-3.30%) up or down from last closing price. If Ajanta Pharma Limited takes out the full calculated possible swing range there will be an estimated 6.60% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ ₹2,193.50, some ₹190.35 (7.98%) from the current price of ₹2,383.85, our system finds the risk reward attractive.

Is Ajanta Pharma Limited stock A Buy?

Ajanta Pharma Limited holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Hold/Accumulate Unchanged

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Ajanta Pharma Limited of Monday, May 6, 2024

Fair opening price May 6, 2024 Current price
₹2,427.97 ( 1.85%) ₹2,383.85

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AJANTPHARM.NS

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2,607.92 9.40 %
R2 2,539.18 6.52 %
R1 2,496.71 4.73 %
Current price: 2,383.85
Support S1 2,359.23 -1.03 %
S2 2,316.76 -2.81 %
S3 2,248.02 -5.70 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 2,383.85
Support S1 2,193.50 -7.98%
S2 2,125.90 -10.82%
S3 2,073.20 -13.03%

AJANTPHARM Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Feb 08, 2024 Feb 08, 2024 Mar 01, 2024 ₹26.00 1.22%
2 Aug 04, 2023 Aug 04, 2023 Aug 04, 2023 ₹15.00 0.86%
3 Nov 11, 2022 Nov 11, 2022 Nov 11, 2022 ₹7.00 0.557%
4 Nov 09, 2021 Nov 09, 2021 Nov 09, 2021 ₹6.33 0.441%
5 Nov 12, 2020 Nov 12, 2020 Nov 12, 2020 ₹6.33 0.621%

FAQ

What is the symbol for Ajanta Pharma Limited Stock and on which exchange is it traded?
The symbol for Ajanta Pharma Limited is AJANTPHARM.NS and it is traded on the NSE (National Stock Exchange of India).

Should I buy or sell Ajanta Pharma Limited Stock?
Ajanta Pharma Limited holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Ajanta Pharma Limited Stock?
Ajanta Pharma Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ajanta Pharma Limited Stock.

What's the current price of Ajanta Pharma Limited Stock?
As of the end of day on the May 03, 2024, the price of an Ajanta Pharma Limited (AJANTPHARM.NS) share was ₹2,383.85.

What is the 52-week high and low for Ajanta Pharma Limited Stock?
The 52-week high for Ajanta Pharma Limited Stock is ₹2,540.00 and the 52-week low is ₹1,246.75.

What is the market capitalization of Ajanta Pharma Limited Stock?
As of the May 03, 2024, the market capitalization of Ajanta Pharma Limited is 300.165B.

When is the next earnings date for Ajanta Pharma Limited?
The upcoming earnings date for Ajanta Pharma Limited is Jul 25, 2024.
Click to get the best stock tips daily for free!

About Ajanta Pharma Limited

Ajanta Pharma Limited Ajanta Pharma Limited, a specialty pharmaceutical formulation company, together with its subsidiaries, develops, manufactures, and markets finished dosages. The company markets and serves various therapeutic segments, such as anti-biotic, anti-malarial, anti-diabetic, cardiology, gynecology, pediatric, respiratory and general health products, dermatology, ophthalmology, and pain management areas. It also provides multivitamins, antibiotics, eye d... AJANTPHARM.NS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT